Q1 2024 Holdings
Filed 2024-05-15 | 77 holdings | $360.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $25.5M | 566,287 | 7.1% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $17.6M | 1,325,065 | 4.9% |
| Morphic Hldg Inc | COM | 61775R105 | $17.0M | 483,972 | 4.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $15.3M | 1,113,007 | 4.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $13.3M | 2,968,798 | 3.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $12.6M | 299,316 | 3.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $12.5M | 489,303 | 3.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.8M | 157,750 | 3.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $11.7M | 1,435,931 | 3.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $11.6M | 190,556 | 3.2% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $11.5M | 3,596,476 | 3.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.1M | 399,949 | 2.8% |
| Perspective Therapeutics Inc | COM | 46489V104 | $9.6M | 8,108,108 | 2.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $8.0M | 183,776 | 2.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.9M | 199,020 | 2.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.6M | 508,587 | 2.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.2M | 6,130,268 | 2.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $7.0M | 478,079 | 2.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.0M | 1,036,667 | 1.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.7M | 561,183 | 1.8% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $6.5M | 1,238,822 | 1.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $6.2M | 280,773 | 1.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $6.0M | 127,835 | 1.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $5.8M | 515,317 | 1.6% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.2M | 500,000 | 1.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.1M | 247,968 | 1.4% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $4.5M | 312,500 | 1.2% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.4M | 776,851 | 1.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.2M | 19,365 | 1.2% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.8M | 398,436 | 1.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $3.5M | 199,415 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.5M | 50,000 | 1.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.3M | 50,000 | 0.9% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $3.2M | 109,892 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.1M | 113,616 | 0.9% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $3.1M | 495,471 | 0.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.9M | 844,235 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.8M | 66,090 | 0.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $2.8M | 20,000 | 0.8% |
| Cerus Corp(CERS) | COM | 157085101 | $2.8M | 1,465,744 | 0.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.7M | 183,392 | 0.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.7M | 101,002 | 0.8% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.6M | 1,000,000 | 0.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.4M | 34,807 | 0.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $2.4M | 99,612 | 0.7% |
| Evogene LTD(EVGN) | SHS | M4119S104 | $2.3M | 3,085,503 | 0.6% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.3M | 501,222 | 0.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.2M | 136,714 | 0.6% |
| Macrogenics IncCall | CALL | 556099909 | $2.1M | 145,500 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.0M | 79,194 | 0.6% |